Back to top

Health Catalyst price target raised to $2.50 from $1.75 at Citi

Citi raised the firm’s price target on Health Catalyst (HCAT) to $2.50 from $1.75 and keeps a Neutral rating on the shares. The firm adjusted ratin...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Health Catalyst, Inc. (HCAT)